News

Colossal’s woolly mammoth patent application, with its descriptions of modified cells and animals, represents “the current ...
Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...
Every year, thousands of tonnes of brown algae are extracted from the seabed to obtain compounds such as alginates, a polymer composed of sugars that has high density and strength, offering potential ...
Life sciences have always been about breakthroughs, but the pandemic revealed a sobering truth: speed and scale are th ...
A biotechnology company called Colossal Biosciences claims to have resurrected the dire wolf, a species that went extinct ...
It has been several months since xAI unveiled Grok 3, the company’s answer to models like OpenAI’s GPT-4o and Google’s Gemini ...
“The de-extinction of the dire wolf and an end-to-end system for de-extinction is transformative and heralds an entirely new ...
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and ...
Big Pharma has aimed some choice words at European countries in recent weeks, including calling the UK “uninvestable” and ...
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...
WELLESLEY HILLS, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of biotech industry veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo to ...